Holen Sie sich die Stockscreener-App
0.6035
54.75%
0.2106
Schlusskurs vom Vortag:
$0.3929
Offen:
$0.8378
24-Stunden-Volumen:
252.02M
Relative Volume:
63.12
Marktkapitalisierung:
$2.64M
Einnahmen:
$79,300
Nettoeinkommen (Verlust:
$-6.92M
KGV:
-0.0318
EPS:
-18.9818
Netto-Cashflow:
$-5.34M
1W Leistung:
+51.39%
1M Leistung:
+12.18%
6M Leistung:
-39.20%
1J Leistung:
-67.31%
1-Tages-Spanne:
$0.592
$0.87
1-Wochen-Bereich:
$0.39
$0.87
52-Wochen-Spanne:
$0.35
$3.20
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
Firmenname
Virax Biolabs Group Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie VRAX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VRAX
Virax Biolabs Group Ltd
|
0.6069 | 1.71M | 79,300 | -6.92M | -5.34M | -18.98 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.90 | 109.90B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
732.25 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
476.96 | 61.42B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
929.00 | 56.36B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
206.67 | 44.06B | 447.02M | -1.18B | -906.14M | -6.1812 |
Virax Biolabs Group Ltd Stock (VRAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-31 | Eingeleitet | H.C. Wainwright | Buy |
Virax Biolabs Group Ltd Aktie (VRAX) Neueste Nachrichten
Ming Shing Group (NASDAQ: MSW) adds Tianhang Zhao to Board, audit chair named - Stock Titan
US Stocks Mixed; Dollar Tree Posts Upbeat Earnings - Benzinga
Virax Biolabs stock rockets after clinical progress in post-infection diagnostics - Investing.com Australia
The LGL Group (NYSE American: LGL) moves warrant deadline from Dec. 9 to Dec. 16, 2025 - Stock Titan
Nu Holdings (NYSE: NU) to add Brazil banking license without changing Nubank brand - Stock Titan
Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders - PR Newswire
Virax Biolabs Releases Interim Financial Results for September 2025 - TipRanks
Will Virax Biolabs Group Limited stock maintain dividend yield - Newser
Is Virax Biolabs Group Limited stock a defensive play in 2025Global Markets & Daily Profit Focused Stock Screening - moha.gov.vn
A Look at Virax Biolabs Group Ltd (VRAX) Shares in the Recent Past Indicates Growth - Setenews
Get in on Titan Mining Corp’s (TII) buy-in window today! - Setenews
How Virax Biolabs Group Limited stock reacts to bond yieldsVolume Spike & Daily Growth Stock Tips - newser.com
Why Virax Biolabs Group Limited stock is favored by pension fundsMarket Volume Summary & Reliable Momentum Entry Alerts - newser.com
Virax Biolabs Group (NASDAQ:VRAX) Trading Down 0% – Time to Sell? - Defense World
Will Virax Biolabs Group Limited stock gain from lower inflationTrade Ideas & Daily Stock Trend Reports - newser.com
Ranking Virax Biolabs Group Limited among high performing stocks via toolsJuly 2025 Selloffs & Smart Swing Trading Techniques - newser.com
Identifying reversal signals in Virax Biolabs Group LimitedJuly 2025 Intraday Action & Low Drawdown Investment Strategies - newser.com
Will earnings trigger a reversal in Virax Biolabs Group LimitedGap Down & Free Real-Time Volume Trigger Notifications - newser.com
Using Python tools to backtest Virax Biolabs Group Limited strategies - newser.com
Real time breakdown of Virax Biolabs Group Limited stock performanceWeekly Market Outlook & Weekly High Return Stock Opportunities - newser.com
Will Virax Biolabs Group Limited stock split again soonJuly 2025 Patterns & Weekly Top Stock Performers List - newser.com
Using Bollinger Bands to evaluate Virax Biolabs Group LimitedSwing Trade & Accurate Intraday Trading Signals - newser.com
Why Virax Biolabs Group Limited stock attracts global investorsJuly 2025 Weekly Recap & AI Enhanced Market Trend Forecasts - Fundação Cultural do Pará
Can IBTA stock reach $100 price targetEarnings Risk Report & Long-Term Safe Investment Plans - Fundação Cultural do Pará
Can machine learning forecast Virax Biolabs Group Limited recoveryCPI Data & Low Volatility Stock Recommendations - newser.com
Virax Biolabs Group Ltd: Incorporating FDA Re - 富途牛牛
Virax Biolabs (NASDAQ: VRAX) receives FDA pre-submission feedback; UK PAIS study at 160 - Stock Titan
What margin trends mean for Virax Biolabs Group Limited stockEarnings Trend Report & Daily Technical Forecast Reports - newser.com
Nature Wood (Nasdaq: NWGL) appoints new CEO and CFO; chair and CEO resign effective Nov. 3 - Stock Titan
Why Virax Biolabs Group Limited stock attracts high net worth investorsPortfolio Gains Report & Real-Time Volume Spike Alerts - newser.com
Long term hold vs stop loss in Virax Biolabs Group Limited2025 Price Momentum & Breakout Confirmation Alerts - newser.com
Cosmos Health expands distribution of Avian Influenza kits - MSN
Is Virax Biolabs Group Limited stock attractive for passive investors2025 Short Interest & Daily Technical Stock Forecast Reports - newser.com
How strong is Virax Biolabs Group Limited stock balance sheetJuly 2025 Fed Impact & AI Driven Price Forecasts - newser.com
What data driven models say about Virax Biolabs Group Limited’s future2025 AllTime Highs & Low Drawdown Investment Ideas - newser.com
Is Virax Biolabs Group Limited stock supported by strong fundamentalsJuly 2025 Highlights & Growth Oriented Trade Recommendations - newser.com
Ryde (NYSE American: RYDE) enters notes & debenture agreement with SEV, access to 200+ EVs - Stock Titan
Does Virax Biolabs Group Limited stock trade at a discount to peersWeekly Profit Analysis & Expert Curated Trade Setup Alerts - newser.com
How sentiment analysis helps forecast Virax Biolabs Group Limited2025 AllTime Highs & Daily Chart Pattern Signals - newser.com
Using RSI to spot recovery in Virax Biolabs Group LimitedPortfolio Profit Report & Verified Swing Trading Watchlists - newser.com
How to build a dashboard for Virax Biolabs Group Limited stockIPO Watch & Technical Entry and Exit Tips - newser.com
Finanzdaten der Virax Biolabs Group Ltd-Aktie (VRAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.73%
0.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):